ALNYLAM PHARMACEUTICALS INC COM USD0.01 financial statements, including revenue, expenses, and profit
The total revenue of 0HD2 for the last quarter is 593.17 M USD, and it's 18.42% higher compared to the previous quarter. The net income of Q4 24 is -83.76 M USD.